TIAFT Young Scientists "Workshop 2001"
Pitfalls associated with the use of a simple sample preparation in the analysis of saliva with LC-ESI-MS/MS
K.A. Mortier*, K.M. Clauwaert**, W.E. Lambert*, J.F. Van Bocxlaer**, E.G. Van den Eeckhout***, C.H. Van Peteghem* and A.P. De Leenheer*
* Laboratory of Toxicology, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium
** Laboratory of Medical Biochemistry and Clinical Analysis, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium
*** Laboratory of Pharmaceutical Biotechnology, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium
The fast analysis of biological fluids with LC-ESI-MS is often hampered by the presence of endogenous compounds. These matrix components restrict the use of a simple sample preparation and short chromatographic run times. Saliva is presented as a relatively clean matrix compared to other biological fluids such as plasma or serum. Indeed, typical matrix components like proteins and lipids are more than twenty times less concentrated.
Hence, a simple protein precipitation sample preparation method for LC-ESI-MS/MS analysis of saliva was developed, which would allow the simultaneous identification and quantification of amphetamines (amphetamine, methamphetamine, MDA, MDMA and MDEA), opiates (codeine, morphine and 6-monoacetylmorphine) and cocaine with its metabolite benzoylecgonine in one single experiment. To 200 microL of saliva, 100 microL of methanol (containing standards and internal standards) and formic acid were added, followed by vortex mixing and centrifugation at high speed. The supernatant was neutralised with ammonia and 50 microL was injected on a phenyl type column (100 x 2.1 mm) which was eluted with a mixture of water, methanol and ammonium formate in a gradient system. A validation of the method was performed, consisting of linearity evaluation, within-day and total-repoducibility, stability of the compounds during analysis, precision and absence of matrix suppression.
As judged by todays bioanalytical validation criteria, the method seemed successful, except for the presence of matrix suppression, which caused erroneous results when analysing the saliva of different individuals spiked with exactly the same quantity of the drugs. To ascertain this conclusion, matrix suppression was further investigated by the continuous postcolumn introduction of MDMA, during the analysis of a blank saliva sample. This allows a visualisation of the ionization suppression by the matrix components, during the entire chromatographic run. It was seen that the ionization was disturbed for almost the entire run. In order to avoid this, a more aggressive protein precipitation was developed. A high amount of acetonitrile (five times the sample volume) and methanolic hydrochloric acid were added to the saliva sample. After centrifugation an amount of supernatant was evaporated and reconstituted. In another experiment an extra ultrafiltration step was incorporated. However, both procedures still suffered from an extensive matrix suppressive effect. Therefore, it was concluded that the LC-ESI-MS/MS analysis of saliva, preceded by an aselective sample preparation, can seriously suffer from ionization suppression by endogenous compounds. Our data clearly demonstrate the need to include evaluation of a suppressive effect by matrix constituents in a validation procedure.
This work was supported grant GOA99-120501.99 and by Eur. Comm. grant SMT4-CT98-2257
ABSTRACTS
- Pitfalls associated with the use of a simple sample preparation in the analysis of saliva with LC-ESI-MS/MS.
K.A. Mortier, K.M. Clauwaert, W.E. Lambert, J.F. Van Bocxlaer, E.G. Van den Eeckhout, C.H. Van Peteghem, and A.P. De Leenheer
- Oral Fluid Testing in Road Traffic - The German Experience within the ROSITA Project
S. Steinmeyer, H. Ohr, and M. R. Moeller
- The use of oral fluid and sweat wipes for the detection of drugs of abuse in impaired drivers
Nele Samyn, Bart Viaene, Bart Laeremans, Gert De Boeck
- Detection of Fluoxetine and Norfluoxetine in Saliva
Fiona M. Wylie and John S. Oliver
- Measurement of Amphetamines in Biological Samples by LC-MS/MS
Michelle Wood, Michael Morris, Donald P Cooper
- Immunochromatographic teststrips for saliva analysis
Jörg Zimmermann1, Nele Samyn, Maria da Costa, Thomas Wuske, Rainer Polzius, Hans-Jürgen Duchstein1
- Determination of MDMA ('Ecstasy') in saliva: a controlled study in recreational users
Monica Navarro, Magi Farré, Simona Pichini, Jordi Ortuño, Pere Nolasc Roset, Ester Menoyo, Jordi Segura, Rafael de la Torre
- Determination of MDMA ('Ecstasy') in saliva with Drugwipe analytical device: a controlled study in recreational users
Monica Navarro, Magi Farré, Simona Pichini, Piergiorgio Zuccaro, Roberta Pacifici, Jordi Ortuño, Pere Nolasc Roset, Ester Menoyo, Jordi Segura, Rafael de la Torre
- Elimination kinetics of oral nandrolone in urine and saliva
V. Cirimele, P. Kintz B. Ludes
- Determination of Cocaine and its Metabolites in Saliva by GC/MS-EI
P. Campora O.; A.M. Bermejo B.; M.J. Tabernero and P. Fernandez.
- The Finnish experience from the ROSITA project
Marielle Grönholm and Pirjo Lillsunde
© 1995-2007 TIAFT |